RxDoctor Payments Data

Lexie Modlin, NP

Family · Clarksville, TNNPI 1689315046

Payments from drug & device makers

$817in general payments, 2019–2025

Across 37 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myriad Genetic Laboratories, Inc.$93
  • Tolmar, Inc.$85
  • Johnson & Johnson$77
  • Merck$76
  • Endo USA, Inc.$69
  • Sumitomo Pharma America, Inc.$67
  • plus $349 from 12 others

What the payments were for

  • Food & beverage$817100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$817 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,142
Medicare patients
257
Services billed
1,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron23$23,615
MyrbetriqMirabegron20$13,684
Trospium Chloride ErTrospium Chloride19$4,743
Tamsulosin Hcl180$3,595
Solifenacin Succinate23$809
Trospium Chloride12$787
Finasteride59$709
Oxybutynin Chloride ErOxybutynin Chloride27$461
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$274
Alfuzosin Hcl ErAlfuzosin Hcl12$232
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$148
Ciprofloxacin Hcl28$133
Fluconazole11$128
Methylprednisolone11$59
Oxycodone Hcl15$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$67$23,61523 claims
Astellas Pharma US IncMyrbetriq$45$13,68420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,706 family providers in Tennessee.

Other family in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →